{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T06:19:28Z","timestamp":1790489968432,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"health and family planning in Jilin province","award":["2015IC007"],"award-info":[{"award-number":["2015IC007"]}]},{"name":"health technology innovation in Jilin province","award":["2017J077"],"award-info":[{"award-number":["2017J077"]}]},{"name":"health and family planning and technological expertise training planning in Jilin province","award":["2016Q043"],"award-info":[{"award-number":["2016Q043"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.cyto.2020.155076","type":"journal-article","created":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T17:40:13Z","timestamp":1586626813000},"page":"155076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Detection of miR-122 by fluorescence real-time PCR in blood from patients with chronic hepatitis B and C infections"],"prefix":"10.1016","volume":"131","author":[{"given":"Zhen-Hua","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Xue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hua","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Guo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jun","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Min","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0484-0421","authenticated-orcid":false,"given":"Da-Lin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cyto.2020.155076_b0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1261\/rna.2183803","article-title":"Tuschl T.A uniform system for micro RNA annotation[J]","volume":"9","author":"Ambros","year":"2003","journal-title":"RNA"},{"key":"10.1016\/j.cyto.2020.155076_b0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/rna.1.2.1066","article-title":"miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1","volume":"1","author":"Chang","year":"2004","journal-title":"RNA Biol."},{"key":"10.1016\/j.cyto.2020.155076_b0015","doi-asserted-by":"crossref","first-page":"17021","DOI":"10.18632\/oncotarget.7740","article-title":"Chronic inflammation contributes to the development of hepatocellular carcinoma by decreasing miR-122 levels","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget."},{"issue":"2","key":"10.1016\/j.cyto.2020.155076_b0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/1354750X.2018.1528631","article-title":"Circulating liver-specific microRNAs as noninvasive diagnostic biomarkers of hepatic diseases in human","volume":"24","author":"Musaddaq","year":"2019","journal-title":"Biomarkers"},{"key":"10.1016\/j.cyto.2020.155076_b0025","first-page":"648e656","article-title":"MiR-122, a paradigm for the role of microRNAs in the liver","author":"Girard","year":"2008484","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.cyto.2020.155076_b0030","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/mt.2008.82","article-title":"Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficientlyin vitro and in vivo","volume":"16","author":"Ely","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cyto.2020.155076_b0035","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nature06783","article-title":"LNA-mediated microRNA silencing in non-human primates","volume":"452","author":"Elm\u00e9n","year":"2008","journal-title":"Nature"},{"issue":"5962","key":"10.1016\/j.cyto.2020.155076_b0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1126\/science.1178178","article-title":"Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection","volume":"327","author":"Lanford","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cyto.2020.155076_b0045","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.cyto.2020.155076_b0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mc.20712","article-title":"Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis","volume":"50","author":"Xu","year":"2011","journal-title":"Mol. Carcinog."},{"issue":"5740","key":"10.1016\/j.cyto.2020.155076_b0055","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.cyto.2020.155076_b0060","doi-asserted-by":"crossref","first-page":"474e484","DOI":"10.1111\/j.1478-3231.2010.02433.x","article-title":"Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C","volume":"31","author":"Morita","year":"2011","journal-title":"Liver Int."},{"issue":"8","key":"10.1016\/j.cyto.2020.155076_b0065","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/jvh.12075","article-title":"Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy","volume":"20","author":"K\u00f6berle","year":"2013","journal-title":"J. Viral. Hepat."},{"issue":"9","key":"10.1016\/j.cyto.2020.155076_b0070","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/jmv.23987","article-title":"Acute Liver Failure Study Group. Micro-RNA-122 levels in acute liver failure and chronic hepatitis C","volume":"86","author":"Dubin","year":"2014","journal-title":"J. Med. Virol."},{"issue":"37","key":"10.1016\/j.cyto.2020.155076_b0075","first-page":"5188","article-title":"Serum levels of microRNAs can specifically predict liver injury of chronic hepatitis B","volume":"18","author":"Zhang","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.cyto.2020.155076_b0080","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1261\/rna.040865.113","article-title":"Enhancement of hepatitis C viral RNA abundance by precursor miR-122 molecules","volume":"19","author":"Cox","year":"2013","journal-title":"RNA"},{"issue":"3","key":"10.1016\/j.cyto.2020.155076_b0085","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jinf.2014.10.017","article-title":"Differences in serum microRNA profiles in hepatitis B and C virus infection","volume":"70","author":"Akamatsu","year":"2015","journal-title":"J. Infect."},{"issue":"2","key":"10.1016\/j.cyto.2020.155076_b0090","first-page":"448","article-title":"MiR-122 - A key factor and therapeutic target in liver disease","volume":"62","author":"Bandiera","year":"2015","journal-title":"J. Hepatol. Eur. Assoc. Study Liver"},{"issue":"AUG","key":"10.1016\/j.cyto.2020.155076_b0095","first-page":"1","article-title":"Prajapati VK. Circulating microRNAs: Potential and emerging biomarkers for diagnosis of human infectious diseases","volume":"7","author":"Verma","year":"2016","journal-title":"Front. Microbiol."},{"issue":"2","key":"10.1016\/j.cyto.2020.155076_b0100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2893.2011.01536.x","article-title":"Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection","volume":"19","author":"Waidmann","year":"2012","journal-title":"J. Viral. Hepat."},{"issue":"2","key":"10.1016\/j.cyto.2020.155076_b0105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1566523214666141224095610","article-title":"miR - 122 is a unique molecule with great potential in diagnosis, prognosis of liver disease, and therapy both as miRNA mimic and antimir","volume":"15","author":"Thakral","year":"2015","journal-title":"Curr. Gene Ther."},{"issue":"6","key":"10.1016\/j.cyto.2020.155076_b0110","first-page":"473","article-title":"Construction and identification of a human liver specific microRNA eukaryotic expression vector","volume":"4","author":"Chen","year":"2007","journal-title":"Cell. Mol. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2020.155076_b0115","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1096\/fj.11-187781","article-title":"A liver-specific microRNA binds to a highly conserved RNA sequence of hepatitis B virus and negatively regulates viral gene expression and replication","volume":"25","author":"Chen","year":"2011","journal-title":"FASEB J."},{"issue":"5","key":"10.1016\/j.cyto.2020.155076_b0120","first-page":"1281","article-title":"miR-122 inhibits viral replication and cell proliferation in hepatitis B virus-related hepatocellular carcinoma and targets NDRG3","volume":"26","author":"Fan","year":"2011","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.cyto.2020.155076_b0125","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/hep.26514","article-title":"Epigenetic regulation of microRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis B virus X protein in hepatocellular carcinoma cells","volume":"58","author":"Song","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2020.155076_b0130","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/onc.2009.211","article-title":"Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties","volume":"28","author":"Coulouarn","year":"2009","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.cyto.2020.155076_b0135","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bbrc.2010.07.021","article-title":"miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV","volume":"398","author":"Qiu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.cyto.2020.155076_b0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nm.1902","article-title":"Decreased levels of miRNA -122 in individuals with hepatitis C responding poorly to interferon therapy","volume":"15","author":"Sarasin-Filipowicz","year":"2009","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cyto.2020.155076_b0145","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.cell.2015.02.025","article-title":"Hepatitis C virus RNA functionally sequesters miR-122","volume":"160","author":"Luna","year":"2015","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.cyto.2020.155076_b0150","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms6408","article-title":"Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors","volume":"5","author":"Israelow","year":"2014","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.cyto.2020.155076_b0155","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1373\/clinchem.2010.147850","article-title":"Plasma microRNA-122 as a biomarker for viral-, alcohol-and chemical-related hepatic diseases","volume":"56","author":"Zhang","year":"2010","journal-title":"Clin. Chem."},{"issue":"1","key":"10.1016\/j.cyto.2020.155076_b0160","first-page":"52","article-title":"Absolute quantification of serum microRNA-122 and its correlation with liver inflammation grade and serum alanine aminotransferase in chronic hepatitis C patients","volume":"30","author":"Wang","year":"2015","journal-title":"Int. J. Infect. Dis."},{"issue":"Pt B","key":"10.1016\/j.cyto.2020.155076_b0165","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.cca.2015.10.002","article-title":"Serum miRNA panel as potential biomarkers for chronic hepatitis B with persistently normal alanine aminotransferase","volume":"451","author":"Tan","year":"2015","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.cyto.2020.155076_b0170","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miroRNA-122, regulation of lipid metabolism revealed by in vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.cyto.2020.155076_b0175","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jhep.2012.10.015","article-title":"Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis","volume":"58","author":"Trebicka","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cyto.2020.155076_b0180","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/hep.24308","article-title":"Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection","volume":"53","author":"Tsai","year":"2011","journal-title":"Hepatology"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620300922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620300922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:55:09Z","timestamp":1760907309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620300922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":36,"alternative-id":["S1043466620300922"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155076","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of miR-122 by fluorescence real-time PCR in blood from patients with chronic hepatitis B and C infections","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155076"}}